| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/15/2006 | US20060128643 Compositions containing a combination of a creatine compound and a second agent |
| 06/15/2006 | US20060128638 Treating atheroma, tumors and other neoplastic tissue; treating atherosclerotic inflammation; forming a complexes with a reducing agent, penetrate and accumulate more rapidly in tumor cells, plaque, increase drug in intracellular concentration; increase photosensitivity |
| 06/15/2006 | US20060128634 Alpha, alpha-disubstituted benzylglycine derivatives as HIV protease inhibitors |
| 06/15/2006 | US20060128629 Angiogenesis inhibitors, antitumor agents |
| 06/15/2006 | US20060128624 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 06/15/2006 | US20060128619 Therapeutic use of modulators of notch |
| 06/15/2006 | US20060128617 Oligoribonucleotide or peptidic nucleic acid inhibiting function of hepatitis c virus |
| 06/15/2006 | US20060128612 Cross-linked glycopeptide-cephalosporin antibiotics |
| 06/15/2006 | US20060128609 N¹- modified glycopeptides |
| 06/15/2006 | US20060128608 Novel chemical compounds and their use |
| 06/15/2006 | US20060128607 Method for inhibiting "melanoma inhibitory activity" mia |
| 06/15/2006 | US20060127979 Capable of generating high titer neutralizing antibody responses against at least two HPV types; prophylactic agents; diagnosis |
| 06/15/2006 | US20060127927 Mammalian IAP gene family, primers, probes, and detection methods |
| 06/15/2006 | US20060127914 Nicotinic acetylcholine receptor |
| 06/15/2006 | US20060127897 Delete sequence in m, tuberculosis, method for detecting mycobacteria using these sequences and vaccines |
| 06/15/2006 | US20060127873 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors |
| 06/15/2006 | US20060127518 Red nocardia cell wall skeleton preparation process and its therapeutic use on treating cervical erosion |
| 06/15/2006 | US20060127487 Antiviral compositions |
| 06/15/2006 | US20060127415 Drying process |
| 06/15/2006 | US20060127414 Immunogenic Composition |
| 06/15/2006 | US20060127411 Immune -modulating peptide made of s.aureus enterotoxin b |
| 06/15/2006 | US20060127395 comprising an E25 anti-IgE antibody and acetic acid ; nasal sprays and slow release formulations drying or freeze-drying; treating an allergic disease |
| 06/15/2006 | US20060127392 Antibody for adcc and inducing cytokine production |
| 06/15/2006 | US20060127378 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 06/15/2006 | US20060127330 Composition for treating and/or preventing periodontal disease |
| 06/15/2006 | US20060127319 dosage form of a mixture of drugs, foaming agents and gases, having improved pharmacokinetics; drug delivery systems |
| 06/15/2006 | CA2630088A1 Signal peptides, nucleic acid molecules and methods of treatment |
| 06/15/2006 | CA2623753A1 Peptides which mimic the antigenic regions of the hepatitis a virus |
| 06/15/2006 | CA2591297A1 Il-7 variants with reduced immunogenicity |
| 06/15/2006 | CA2590500A1 Use of egf to treat or prevent pathogenic infections and to promote weight gain |
| 06/15/2006 | CA2590141A1 Saquinavir derivatives useful in immunoassay |
| 06/15/2006 | CA2585104A1 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 06/14/2006 | EP1669379A1 3,5-dimethyl-1-adamantyl-ammonium polymeric salts and the use thereof in the form of antiviral agents |
| 06/14/2006 | EP1669368A1 Use of peptides from the E2 protein of HCV for treating HCV infection |
| 06/14/2006 | EP1669364A2 Methods and compositions for treating hepatitis C virus |
| 06/14/2006 | EP1669357A1 SUBSTANCE WHICH EXHIBITS ANTIVIRAL AND ANTIBACTERIAL ACTIVITY AND IS BASED ON DERIVATIVES OF 2,8-DITHIOXO-1H-PYRANO 2,3D&cedi l;6,5-D DIPYRIMIDYNE AND 10-AZA-ANALOGUE THEREOF |
| 06/14/2006 | EP1669354A1 8-cyanoquinolonecarboxylic acid derivative |
| 06/14/2006 | EP1669077A1 Antibacterial compositions of n-acetyl-d-aminoglycosamine and antibiotics |
| 06/14/2006 | EP1668023A1 B-l-nucleosides and use thereof as pharmaceutical agents for treating viral diseases |
| 06/14/2006 | EP1668009A1 Hcv inhibitors and methods of using them |
| 06/14/2006 | EP1667998A2 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 06/14/2006 | EP1667994A1 Quinolone antibacterial agents |
| 06/14/2006 | EP1667741A1 Cyanoacrylate monomer formulation containing diiodomethyl-p-tolylsulfone |
| 06/14/2006 | EP1667715A2 Antigen delivery system |
| 06/14/2006 | EP1667713A1 Measles subunit vaccine |
| 06/14/2006 | EP1667695A2 Oligonucleotides targeting prion diseases |
| 06/14/2006 | EP1667694A2 Tlr7 ligands for the treatment of hepatitis c |
| 06/14/2006 | EP1667657A1 Topical aerosol foams |
| 06/14/2006 | EP1667656A1 Compositions and methods for delivery of biologically active agents |
| 06/14/2006 | EP1476434B1 Pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 06/14/2006 | EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 06/14/2006 | EP1381373B1 Medical compositions for use in the treatment or prevention of a functional vitamin b12 deficienfcy |
| 06/14/2006 | EP1349836B1 Tetracyclic derivatives as spla2 inhibitors |
| 06/14/2006 | EP1268418B1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 06/14/2006 | EP1214324B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/14/2006 | EP1210100B1 Method of treating traumatic brain using non-steroidal anti-inflammatory drugs |
| 06/14/2006 | EP1175205B1 Solid dispersion comprising ritonavir, fenofibrate or griseofulvin |
| 06/14/2006 | EP1135115B1 Use of sibutramine for the treatment of disorders of the central nervous system secondary to organic impairments |
| 06/14/2006 | EP1119370B1 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 06/14/2006 | EP1102596B1 Peptide antagonists of zonulin and methods for use of the same |
| 06/14/2006 | EP1097210B1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 06/14/2006 | EP1071468B1 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor |
| 06/14/2006 | EP1033129B1 Antimicrobials for treating peptic ulcer |
| 06/14/2006 | EP0783321B1 Vr-2332 viral nucleotide sequence and methods of use |
| 06/14/2006 | EP0757556B1 Borrelia burgdorferi bacterin |
| 06/14/2006 | DE102005055385A1 Arzneimittel zur hygienischen Applikation im Ohr Medicines for hygienic application in the ear |
| 06/14/2006 | DE102004059361A1 Use of oligomeric carbohydrate-lignin complex containing aqueous hardwood extract (e.g. beech wood extract) as anti-infective and for the preparation of medicaments, and in food products or feed industry |
| 06/14/2006 | CN1788084A Crystal structure of human coronavirus 229E main proteinase, and uses thereof for developing SARS inhibitors |
| 06/14/2006 | CN1788018A Human monoclonal antibody specific for lipopolysaccharides (LPS) of serotype IATS 06 of pseudomonas aeruginosa |
| 06/14/2006 | CN1788013A New 3-decladinosyl 9a-n -carbamoyl and 9a-n -thiocarbamoyl derivatives of 9-deox-9-dihydro-9a-aza-9a-homoerythromycin a |
| 06/14/2006 | CN1788006A Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 06/14/2006 | CN1788000A Phthalazinone derivatives |
| 06/14/2006 | CN1787836A Avian combination-vaccine against e.coli and salmonella |
| 06/14/2006 | CN1787829A Composition against infection with rotavirus and process for producing the same |
| 06/14/2006 | CN1786034A Preparation method of umbellate pore fungus polysaccharide sulphate |
| 06/14/2006 | CN1786020A Inhibition peptide of hepatatitis B virus polyzymoprotein YMDD functional region and its application |
| 06/14/2006 | CN1786000A Sodium salt of Entecavir, its preparation method and pharmaceutical application |
| 06/14/2006 | CN1785996A Antifungus compound, its preparation method and application |
| 06/14/2006 | CN1785993A Preparation method of non natural isocumarin and its 3,4-dihydro derivative and use thereof |
| 06/14/2006 | CN1785978A Tetra hydro iso quinoline compounds possessing anti breed and anti fungus activity and its salt |
| 06/14/2006 | CN1785965A Antifungus compound, its preparation method and application |
| 06/14/2006 | CN1785428A New lysozyme compound injection preparation |
| 06/14/2006 | CN1785425A Preparation method of poly peptide vaccine for treating lefteye flounder adenolymphocele |
| 06/14/2006 | CN1785407A Medicine for enhancing human body immune function and treating Aids and its preparation method |
| 06/14/2006 | CN1785385A Cassia oil composition and its application in making medicine |
| 06/14/2006 | CN1785384A Chinese medicinal composition for treating tuberculosis and its preparation method |
| 06/14/2006 | CN1785379A Medicinal preparation for treating hepatitis B and its preparation method |
| 06/14/2006 | CN1785361A Traditional Chinese medicine for antimicrobiology. antinflammation, phlegm transformation, calm panting |
| 06/14/2006 | CN1785357A Chinese medicinal preparation for treating virus myocaraitis, its preparation method and quality control method |
| 06/14/2006 | CN1785356A Oral medicine for treating trachoma |
| 06/14/2006 | CN1785351A Soft capsule for trenting acute, chronic hepatitis B and its preparation method |
| 06/14/2006 | CN1785317A Chinese and western medicine compounl powder preparation for freating hog dysentery |
| 06/14/2006 | CN1785265A Hepatitis B support right fast dispersion solid preparation and its preparation method |
| 06/14/2006 | CN1785264A Chinese medicinal composition for treating strangury patterns and preparation method of its oral liquid, tablet and capsule |
| 06/14/2006 | CN1785258A Tea tree oil liposome and its preparation method |
| 06/14/2006 | CN1785257A Tincture for trenting fungus dermatosis |
| 06/14/2006 | CN1785256A External use medicine for treating dermatosis |
| 06/14/2006 | CN1785254A Effective capsule for treating and preventing Aids |
| 06/14/2006 | CN1785244A Traditional Chinese medicine prepn. for treating tuberculosis |
| 06/14/2006 | CN1785242A Compounding wild chrysanthemum membrane agent |